Ryan’s Quest, Michael’s Cause, and Pietro’s Fight have committed the $400,000 in seed capital toward developing DMD-813, which has shown promise in preclinical studies
From http://kianorshahmohammadi.com/post/158000558215
source https://dentaleconomicsus.wordpress.com/2017/03/04/startup-wins-400k-from-foundations-to-develop-dmd-candidate-gen-genetic-engineering-biotechnology-news-biotech-from-bench-to-business-gen/
No comments:
Post a Comment